Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,295,897
  • Shares Outstanding, K 360,990
  • Annual Sales, $ 8,434 M
  • Annual Income, $ -948,000 K
  • 60-Month Beta 1.35
  • Price/Sales 0.27
  • Price/Cash Flow 0.70
  • Price/Book 8.96
Trade BHC with:

Options Overview Details

View History
  • Implied Volatility 100.68% ( -0.73%)
  • Historical Volatility 175.89%
  • IV Percentile 87%
  • IV Rank 29.56%
  • IV High 266.78% on 07/28/22
  • IV Low 30.99% on 09/03/21
  • Put/Call Vol Ratio 1.32
  • Today's Volume 10,484
  • Volume Avg (30-Day) 26,987
  • Put/Call OI Ratio 0.97
  • Today's Open Interest 454,790
  • Open Int (30-Day) 385,211

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 1.04
  • Number of Estimates 4
  • High Estimate 1.12
  • Low Estimate 0.95
  • Prior Year 1.14
  • Growth Rate Est. (year over year) -8.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.00 +48.50%
on 07/28/22
9.34 -36.40%
on 07/20/22
-2.76 (-31.72%)
since 07/15/22
3-Month
4.00 +48.50%
on 07/28/22
11.09 -46.44%
on 05/18/22
-5.09 (-46.15%)
since 05/17/22
52-Week
4.00 +48.50%
on 07/28/22
29.59 -79.93%
on 09/03/21
-21.65 (-78.47%)
since 08/17/21

Most Recent Stories

More News
Bausch (BHC) to Appeal Regarding Xifaxan Patent Decision

Bausch (BHC) will appeal to the U.S. Court of Appeals for the Federal Circuit regarding the patent decision for one of its key drugs Xifaxan.

NVS : 85.22 (-0.70%)
TEVA : 10.01 (-9.25%)
BHC : 5.94 (-6.60%)
Bausch (BHC) Q2 Earnings & Sales Miss, View Cut, Stock Down

Bausch (BHC) Q2 earnings and sales miss in the second quarter. The company cuts its annual guidance due to the uncertainties in the overall operating environment.

DVAX : 12.76 (-10.39%)
ALKS : 25.61 (-3.18%)
NVAX : 39.37 (-8.19%)
BHC : 5.94 (-6.60%)
Stocks Fall on Caution Ahead of CPI Report

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.42%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 4,274.04 (-0.72%)
SPY : 426.65 (-0.71%)
$DOWI : 33,980.32 (-0.50%)
DIA : 340.20 (-0.45%)
$IUXX : 13,470.86 (-1.21%)
QQQ : 328.49 (-1.14%)
MU : 61.62 (-3.51%)
NVDA : 183.35 (-2.88%)
AMD : 98.27 (-1.93%)
INTC : 35.78 (-1.13%)
NCLH : 13.80 (-5.22%)
RCL : 41.86 (-5.04%)
Why Bausch Health Stock Tumbled More Than 11% on Tuesday

Investors are increasingly realizing the scope of the turnaround project CEO Thomas Appio has on his plate.

BHC : 5.94 (-6.60%)
Stocks Fall on Caution Ahead of CPI Report

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.31%....

$SPX : 4,274.04 (-0.72%)
SPY : 426.65 (-0.71%)
$DOWI : 33,980.32 (-0.50%)
DIA : 340.20 (-0.45%)
$IUXX : 13,470.86 (-1.21%)
QQQ : 328.49 (-1.14%)
MU : 61.62 (-3.51%)
NVDA : 183.35 (-2.88%)
AMD : 98.27 (-1.93%)
INTC : 35.78 (-1.13%)
NCLH : 13.80 (-5.22%)
RCL : 41.86 (-5.04%)
U.S. Stocks Undercut as T-note Yield Rises

Morning Markets September S&P 500 futures (ESU22 ) this morning are down -0.23%. Stock investors have turned cautious ahead of tomorrow’s U.S. July CPI report, which will be a key factor for the Fed...

ESU22 : 4,272.75 (-0.09%)
MU : 61.62 (-3.51%)
NVDA : 183.35 (-2.88%)
AMD : 98.27 (-1.93%)
NCLH : 13.80 (-5.22%)
^BTCUSD : 23,460.68 (+0.25%)
COIN : 85.44 (-5.48%)
MARA : 15.45 (-8.47%)
RIOT : 8.35 (-8.94%)
BHC : 5.94 (-6.60%)
Bausch Health (BHC) Q2 Earnings and Revenues Miss Estimates

Bausch (BHC) delivered earnings and revenue surprises of -38.20% and 3.84%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

BHC : 5.94 (-6.60%)
FIXX : 2.78 (-3.81%)
Drug, Biotech Stocks' Q2 Earnings on Aug 9: EXEL, BHC & More

Let us look at four drug and biotech companies, EXEL, BHC, CPRX and AXSM, which are gearing up for their earnings release.

EXEL : 19.31 (-1.03%)
CPRX : 13.73 (-1.72%)
AXSM : 43.13 (-2.53%)
BHC : 5.94 (-6.60%)
Supernus Pharmaceuticals (SUPN) Q2 Earnings Lag Estimates

Supernus (SUPN) delivered earnings and revenue surprises of -53.33% and 2.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SUPN : 33.51 (-1.38%)
BHC : 5.94 (-6.60%)
Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates

Personalis (PSNL) delivered earnings and revenue surprises of 4.76% and 21.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

PSNL : 4.48 (-6.08%)
BHC : 5.94 (-6.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic...

See More

Key Turning Points

3rd Resistance Point 6.44
2nd Resistance Point 6.33
1st Resistance Point 6.14
Last Price 5.94
1st Support Level 5.84
2nd Support Level 5.73
3rd Support Level 5.54

See More

52-Week High 29.59
Fibonacci 61.8% 19.81
Fibonacci 50% 16.80
Fibonacci 38.2% 13.78
Last Price 5.94
52-Week Low 4.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar